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Introduction: The purpose of the study was to compare different parameters used in Ranson’s Criteria, Bedside 
Index of Severity in Acute Pancreatitis (BISAP), Acute Physiology and Chronic Health Evaluation (APACHE-II), 
and modified computed tomography severity index (MCTSI) for predicting the severity of acute pancreatitis and 
formulate a new scoring system to assess the severity of acute pancreatitis based on their prognostic severity 
index in the local population. 
Materials and Methods: This prospective pilot study was conducted at Rawalpindi Medical University allied 
hospitals from August 2019 to December 2019. All patients with a diagnosis of acute pancreatitis were included in 
the study through non-probability convenient sampling. Different scoring parameters were entered into 
standardized proforma.  
Results: 100 patients were included in the pilot study with a mean age of 46.53 ± 15.324. Among 24 parameters 
from APACHE-II, Ranson’s, BISAP, and MCTSI, only 11 parameters, Pleural effusion (PE), Pancreatic necrosis 
(PN), LDH, serum Calcium (Sca++), Pulse, GCS, MCTS1, Base deficit, Po2, BUN-24 and BUN-48 were 
significantly related(at 10% level of significance) with the severity of acute pancreatitis. Similarly out of 24, 10 
parameters AST, LDH, Sca++, Pulse, PE, PN, Base deficit, MCTS1, Po2, and BUN 48were significantly covered 
more than 50% of the area in AUC analysis. Our proposed criteria based on 9 parameters LDH, Sca++, Pulse, PE, 
PN, Base deficit, MCTS1, Po2, and BUN 48which were blowing by the two methods (ANOVA and ROC). The 
sensitivity and specificity were higher with our proposed criteria 93.1% and 60.6%respectively as compared to the 
Ranson’s, modified Ranson, BISAP, and APACHE-II criteria. 
Conclusion: The newly proposed criteria for the assessment of the severity of AP is superior as compared to old 
criteria. 
Keywords: Acute Pancreatitis, Ranson’s Criteria, Modified Ranson criteria, BISAP criteria, APACHE II criteria.  
 




Acute pancreatitis is a severe disease of the pancreas 
with significant morbidity and mortality. The 
worldwide annual incidence of acute pancreatitis is 
increasing and it is about 5 to 80 cases per year per 
100,000. Its mortality is about 1 to 7% and can increase 
up to 20% depending upon disease severity. The 
increase in mortality directly related to organ failure.1-3 
Gallstone and alcohol abuse together responsible for 
70-80% of all cases of acute pancreatitis.4-7 AP has an 
overall mortality of 5-10%. 80-90% cases are mild, self-
limited with a fair outcome. The remaining 10-20% of 
cases with severe pancreatitis have variable pancreatic 
necrosis or organ failure and need ICU care with 
possible operative intervention and mortality rate of 
about 40%.14 
Acute pancreatitis diagnosed based on two of the 
following three criteria: 
1. Characteristic acute pancreatitis abdominal 
pain 
2. Amylase and/or lipase serum levels at least 
three times upper limit of normal; and 
3. Acute pancreatitis characteristic findings on 
abdominal ultrasonography and/or 
computerized tomography (CT) scan.  
AP severity is classified as mild, moderately severe, 
and severe according to Atlanta classification 2012. 
Mild AP had neither local complications nor organ 
failure. Moderately severe acute pancreatitis had 
transient organ failure or local complications or both, 
and severe acute pancreatitis had persistent organ 
failure.8,15 
Different scoring systems based on clinical and 
biochemical data had been used for the past few 
decades. These include APACHE-II, Ranson’s, BISAP, 
Glasgow-Imrie, and MCTSI. Each  has its limitations 
like low sensitivity, specificity, and complexity  as well 
as an inability to obtain a final score until 48 hours 
after admission.16 
The rationale of this study is to compare different 
parameters used in Ranson’s, BISAP, APACHE-II, and 
MCTSI for the severity of acute pancreatitis and design 
new criteria to assess the severity of AP  at the local 
population because the etiology of acute pancreatitis is 
different as compared to western population, that may 
be cost-effective and more simple.17,18 
Objective: To compare parameters used in different 
scoring systems for the severity of acute pancreatitis 
and formulate a new scoring system for assessing the 
severity of acute pancreatitis in our population. 
Materials and Methods 
 
Study Design: Prospective study.  
Setting: Rawalpindi Medical University and Allied 
Hospitals. 
Period: Pilot study (6 months from July 2019 to 
December 2019) 
Sample size: We validate our sample size for this pilot 
study through the WHO sensitivity specificity sample 
size calculator. Keeping sensitivity 93.1%, specificity 
60.6%, the proportion of severe/moderate cases of AP 
(which is in our sample of 100 is observed) 29% and 
with precision 14%, the minimum sample size is 98 
hence we include 100 patients for this pilot study.  
Methods: All admitted patients with acute pancreatitis 
at Rawalpindi medical university allied hospitals were 
included in the study. Data collected through 
standardized Performa. All acute pancreatitis patients 
of either gender, having age over 12 years, reporting to 
the accident and emergency department, were 
included in the study. Informed consent was taken 
from all patients.  
After the history and physical examination, laboratory 
investigations were sent at the time of admission, CBC, 
hematocrit, serum amylase and lipase, liver function 
test, kidney function test, serum electrolytes, LDH, 
ABG analysis, and blood sugar. All patients have 
abdominal ultrasonography at the time of admission 
and contrast-enhanced pancreatic protocol CT scan 2-7 
days after symptoms onset. 
Patients examined daily and investigations relevant to 
Ranson’s, BISAP, and APACHE-II scores were noted. 
BISAP was calculated within the first 24 hours of 
admission and Ranson’s score was evaluated within 
the first 48 hours of admission. Computed 
Tomography is carried out according to patient 
condition but preferably within two to seven days 
after admission. 
Data Analysis Procedure: The collected data of 
diagnosed cases of AP were included and analyzed 
using SPSS version 23. AP patients classified according 
to Atlanta classification 2012.  Pancreatic necrosis, 
need for ICU care and length of hospital stay were also 
observed. The final grade of AP was decided 
according to Atlanta 2012 classification. For the first 
part of our objective, we first examined thorough 
mean comparison (ANOVA), proportion comparison 
(Chi-square), and ROC from 24 parameters, how many 
were related to the severity of the disease in our 
sample. Then for the new index, we selected those 
parameters that were related to the severity of the 
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disease and also cover more than 50% area under the 
curve. Lastly, we calculated Ranson’s score, Modified 
Ranson’s score, BISAP, and APACHE II, and the 
sensitivity, specificity, and Area Under the Curve 
(AUC) were also calculated. We calculated the 
sensitivity, specificity, and AUC of our proposed 
criteria and found a better model through sensitivity, 




Out of 100 cases, 53 were female and 47 were male. 
Only 10 patients were admitted to ICU for additional 
care. The average age of the patients was 46.53 ± 
15.324 years ranged between 14 to 88 years of age. The 
patients having comorbid DM, HTN, and DM & HTN 
were 20%, 9%, and 10% respectively. Out of 100 
patients, 75% biliary, 4% alcoholic, 5% post ERCP, 3% 
hyperlipidemia, and 1% tumor and 12% have other 
etiology. 
We examined 24 parameters Sex, Age, White blood 
cells (WBC), Random blood sugar (RBS), Aspartate 
aminotransferase (AST), Lactic Acid Dehydrogenase 
(LDH), Hematocrit (HCT), Serum Calcium (SCa), 
Respiratory rate (RR), Pleural Effusion (PE), Pulse, 
GCS, Temperature, PN, MCTS1, Base deficit, Fluid 
Sequestration (FS), Po2, Ph. Arterial, Creatinine(Cr), 
BUN 24 hours, BUN 48 hours, MAP, Sodium(Na) and 
Potassium(K) in all selected patients and related the 
above parameters with the severity of the disease.  
To test the relation between qualitative parameters 
and severity categories we used the chi-square test. 
Proportions of mild, moderate, and severe cases were 
not the same between patients having PE positive and 
negative with p-value 0.001. Similarly, there was no 
relation between PN and severity of the AP with p-
value 0.000. The detail is mentioned in Table 1. 
We compared all quantitative parameters between 
severity categories of the patients i.e. Mild, Moderate, 
and Severe through ANOVA. The mean values of 9 
parameters LDH, Sca++, Pulse, GCS, MCTS1, Base 
deficit, Po2, BUN-24 and BUN-48 were significantly 
different  between 3 categories having p-value 0.027, 
0.001, 0.000, 0.000, 0.000, 0.008, 0.001, 0.017, 0.000. The 
reason behind the use of a 10% level of significance 
rather than 5% is that as this is a pilot study and the 
variable which is significant at 10%, at this stage, have 
very much chances of significant at 5% on final 
analysis with the higher number of cases.  
Similarly, with the second method and for verification, 
we use Receiver Operative Curve (ROC) which gives 
us a second opinion regarding the relationship 
between parameters and the severity of the disease. 
Through the receiver operative curve, we also find the 
cut points (corner points) where the severity of AP is 
changed from one category to another. 10 out of 24 
parameters AST, LDH, Sca++, Pulse, PE, PN, Base 
deficit, MCTS1, Po2 and BUN 48 have significantly 
covered the area under the curve with p-value 0.042, 
0.072, 0.002, 0.015, 0.000, 0.001, 0.023, 0.000, 0.096 and 
0.018 respectively. The detailed results of AUC 
analysis are mentioned in Table 3.  
Based on the above analysis, we formed new criteria 
for the assessment of the severity of the disease. The 
new criteria were based on the 9 parameters PE, PN, 
LDH, Sca++, MCTS1, Base deficit, Po2, BUN 48, and 
Pulse, which were highlighted through both ANOVA 
and AUC analysis. The descriptive analysis of the 
selected parameters for the proposed criteria as 
mentioned in Table 4.  
The AUC with proposed criteria (A) was 0.84 with a p-
value of 0.000 whereas the sensitivity, specificity, PPV, 
and NPV were 93.1%, 60.6%, 53.5%, and 89.5% 
respectively. Interestingly, the cut off value in either 
case (proposed criteria A or in final proposed criteria) 
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Table 1: Relationship between qualitative parameters and severity of the disease 
Variable Categories Severity of the disease p-value 
Mild Moderate Severe 
PE Yes 17 14 7 0.001 
No 54 7 1 
PN No 56 12 0 0.000 
 Less or equal to 30% 14 4 3 
 More than 30% 1 5 5 
 
Table 2: Mean comparison of quantitative parameters between different categories of AP with respect to the 
severity of the disease 
Variable Severity of the disease P-value 
Mild (n=71) Moderate (n=21) Severe (n=8) 
LDH 487.90 ± 311.409 655.29 ± 519.611 818.63 ± 519.407 0.027 
Serum Calcium 8.6577 ± 1.1591 7.5957 ± 1.0706 8.8263 ± 1.4376 0.001 
MCTS1 3.04 ± 2.161 5.81 ± 2.600 8.25 ± 2.252 0.000 
Base deficit 2.5827 ± 3.472 4.4095 ± 6.2195 10.9525 ± 21.9608 0.008 
Po2 78.64 ± 11.17 76.76 ± 11.606 62.13 ± 12.276 0.001 
BUN at 24 hours 15.2063 ± 5.2652 17.5067 ± 7.5316 22.9925 ± 18.1058 0.017 
BUN at 48 hours 14.5669 ± 4.2094 17.7795 ± 6.9649 26.8763 ± 19.8948 0.000 
Pulse 89.97 ± 9.823 93.00 ± 11.415 106.75 ± 15.709 0.000 
GCS 14.99 ± 0.119 14.95 ± 0.218 14.5 ± 0.926 0.000 
 
Table 3: Diagnostic accuracy of the parameters with respect of the severity of the disease 
Variable Cut off point Area under the curve Sensitivity Specificity  P-value 
PE 1 0.742 0.724 0.761 0.000 
PN More than 30% 0.665 0.345 0.986 0.01 
LDH 473 0.615 0.552 0.577 0.072 
Sca++ 8.65 0.301 0.207 0.507 0.002 
MCTS1 5 0.833 0.724 0.845 0.000 
Base deficit 2.2 0.646 0.655 0.521 0.023 
Po2 78.5 0.394 0.345 0.549 0.096 
BUN 48 14.005 0.652 0.69 0.507 0.018 
Pulse 89.5 0.656 0.655 0.507 0.015 
AST 144.75 0.37 0.31 0.507 0.042 
 
Table 4: Descriptive analysis of quantitative parameters used in proposed criteria 
Parameters Mean ± Standard deviation Minimum Maximum 
LDH 549.51 ± 391.327 77 2013 
Sca++ 8.4482 ± 1.2348 5.7 11.68 
MCTS1 4.04 ± 2.799 0 10 
Base deficit 3.6359 ± 7.4624 -2 65 
Po2 76.92 ± 12.079 42 100 
BUN 48 16.2263 ± 7.8719 2.5 62 
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Table 5: Comparison of different criteria with the proposed criteria for measurement of severity of the disease  
Criteria Cut off point Area p-value Sensitivity Specificity 
Ranson’s 5.5 0.501 0.988 31% 76.1% 
M.Ranson’s 3.5 0.524 0.713 48.3% 54.9% 
BISAP 5.5 0.711 0.001 62.1% 74.6% 
APACHE II 9.5 0.636 0.033 62.1% 66.2% 




Acute pancreatitis is a common disease encountered 
by medical professionals all over the world. It is 
critical to identify those patients who have severe 
disease and benefit from early intensive care. In most 
cases of AP, it is very difficult to assess the severity 
clinically alone. 
Various scoring systems incorporating clinical and 
biochemical criteria for severity assessment of AP have 
been in use for the last few decades. Among these, 
Ranson’s et al. in 1970 included  11 measures9, 
Glasgow score (08 measures)10, MOSS score (12 
measures), BISAP  (05 measures), and APACHE II 
score (14 measures).11 The sensitivity and specificity of 
these systems for predicting the severity of acute 
pancreatitis range between 55% and 90%, depending 
on the cut-off number and timing of scoring.12 
Limitations of these systems have been either a very 
low diagnostic accuracy of different parameters in48 
hours (Ranson and Glasgow scores) or the complexity 
of the scoring system itself (APACHE II). The 
APACHE-II score has not been developed specifically 
for acute pancreatitis but has been proven to be an 
early and reliable tool for organ failure.  
Ranson’s criteria have 11 parameters and recorded on 
admission and at 48 hrs, but its primary aim was to 
evaluate the early operative intervention in patients 
with AP. A composite score of 3 or more is used to 
classify a patient as having severe pancreatitis. In our 
study, the ROC analysis gives a very low AUC 50.1% 
with the best cutoff point 6 or more. On that cut point, 
sensitivity and specificity also not very impressive 
with 31% and 76.1% respectively.  
The APACHE II score has the advantage to assess 
patients at any time during the illness but very 
cumbersome for routine clinical use. The sensitivity, 
specificity, and AUC were the best among the different 
old criteria to measure the sensitivity of the disease 
having 62.1%, 66.2%, and 63.6% respectively. 
In this pilot study, we have 24 parameters from 
Ranson, BISAP, APACHE-II, MCTSI, and observed 
their correlation with the severity of acute pancreatitis. 
We confirmed that different parameters can be used as 
a reliable marker for early stratification of the severity 
of acute pancreatitis. 
In our pilot study, the mean age of the study 
population was 46.5 years with a slight female 
predominance. Out of 100 patients, 71 (mild), 21 
(moderately severe) disease, and 7 have severe 
pancreatitis. Gall stone pancreatitis was found in 75 
(75%) cases and alcoholic in only four cases. Nine 
parameters correlate with the severity of pancreatitis 
with a p-value <0.05. Amongthesepulse with mean 106 
± 15 in severe pancreatitis patients, pleural effusion 
was present in 7/8, LDH with 818 ± 519 in severe 
disease, were analysed at the arrival of patient in the 
hospital and base deficit with a mean 10.95 ± 21.96, 
po2 with mean 62 ± 12, Sca with mean 8.82 ± 1.43 and 
BUN 48 with mean 26 ± 19 at 48 hours of admission. 
PN 30% or >30% were present in all severe pancreatitis 
patients and MCTSI with a mean 8.25 ± 2.25 score 
were assessed between 2-7 days after the patient in a 
hospital stay. 
The proposed criteria are based on 9 parameters, most 
of them will be easily available when a patient with 
acute pancreatitis visited the emergency department. 
The proposed criteria cover 84% variation in the 
severity of the disease at the value 4 or more, which is 
significantly greater than 50% with p-value 0.000. The 
sensitivity, specificity, positive predictive value, and 
negative predictive value of the criteria is also higher 
as compared to the previously designed old criteria. 
Hence the proposed criteria are efficient, give a better 
result in less time, and cost-effective. We will validate 




Based on our pilot sample, we conclude that it is 
necessary to design new and better criteria for our 
population as acute pancreatitis patients in our study, 
have a different proportion of etiology as compared to 
the western population. As this pilot study results 
show that our newly proposed criteria for the severity 
of AP are superior for our sample, hence we will be 
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able to design a better index when we observe the 
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